What is it about?
Dental management of patients on antiplatelet therapy is still not clearly defined: the discontinuation of antiplatelet therapy increases the risk of thrombotic complications, whereas uninterrupted antiplatelet therapy is assumed to increase the bleeding complications after dental surgical procedures.
Featured Image
Why is it important?
The aim of this article is to review the main antiplatelet drugs used for long-term oral antiplatelet therapy, the laboratory methods for evaluating effectiveness of this therapy, to identify the studies and guidelines available for dental management of patients on antiplatelet drugs and to summarize their conclusions and recommendations
Read the Original
This page is a summary of: DENTAL MANAGEMENT AND BLEEDING COMPLICATIONS OF PATIENTS ON LONG-TERM ORAL ANTIPLATELET THERAPY. REVIEW OF EXISTING STUDIES AND GUIDELINES., Journal of IMAB - Annual Proceeding (Scientific Papers), June 2013, Journal of IMAB,
DOI: 10.5272/jimab.2013192.298.
You can read the full text:
Resources
Contributors
The following have contributed to this page







